Featured Funding Needs
Heart & Vascular Center
How MetroHealth's Heart & Vascular Center Makes a Difference
One of the busiest clinical programs at MetroHealth, the Heart & Vascular Center is proud to hold a number of distinctions in cardiovascular care including:
- Among the elite hospitals in the nation, MetroHealth has been the only hospital in Northeast Ohio to receive Triple Gold Performance Achievement Awards for the treatment of coronary heart disease, heart failure, and stroke from the American Heart Association’s Get With the Guidelines program. Few hospitals follow these approved guidelines that ensure best patient outcomes.
- Partnered with the Cleveland Clinic in cardiac surgery, MetroHealth has among the lowest mortality rates in the region.
- Pioneered new methods to identify patients at risk for sudden cardiac death. A more advanced stress test of sorts, called T-wave alternans test, is a non-invasive way to save lives that has been adopted by cardiologists around the world.
- One of the nation’s leading centers for the development of gene therapy and stem cell therapy for the treatment of life-threatening cardiac arrhythmias. Investigators have developed tools for switching specific genes in the heart "on" or "off" to alter progression of heart disease.
- Attracted $15 million of National Institute of Health (NIH) funding to support 15 currently active clinical trials.
Rakita-Moss Endowed Professorship (Make a Donation)
The Rakita-Moss professorship honors two physicians, one who devoted 54 years of service to MetroHealth, and another who recognized that extraordinary commitment with an initial gift to establish this endowment. The professorship honors this legacy by supporting a cardiologist who exemplifies dedication to patient care, teaching, and cardiac research advancements. We must continue to identify donors and alumni interested in ensuring MetroHealth’s excellence in cardiac care.
Robert Bahler Endowed Professorship (Make a Donation)
This professorship supports key research and teaching programs in the Heart & Vascular Center. Dr. Bahler is a former Chief of Cardiology at MetroHealth who continues to treat large numbers of patients for heart disease. This program provides an important tool for recruiting nationally recognized physician leaders to MetroHealth.
Facility for Innovative Cardiovascular Therapies (Make a Donation)
Heart disease is the number-1 killer in the U.S. The primary reason for cardiovascular death is sudden cardiac arrest from cardiac arrhythmias. The success of the Heart & Vascular Center’s gene and stem cell therapy programs will be leveraged to develop a new facility where these therapies are delivered to patients, ultimately altering the natural progression of heart disease. The Facility for Innovative Cardiovascular Therapies will include an electrophysiological mapping system, enhancing state-of-the-art care for our patients.
Make a gift to the Heart and Vascular Center
Donate to another need at MetroHealth